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Despite the key role of primary and secondary
lymphoid organ stroma in immunity, our understand-
ing of the heterogeneity and ontogeny of these cells
remains limited. Here, we identify a functionally
distinct subset of BP3PDPN+PDGFRb+/a+CD34+
stromal adventitial cells in both lymph nodes (LNs)
and thymus that is located within the vascular niche
surrounding PDPNPDGFRb+/aEsam-1+ITGA7+
pericytes. CD34+ adventitial cells developed in late
embryonic thymus and in postnatal LNs and in the
thymus originated, along with pericytes, from a com-
mon anlage-seeding progenitor population. Using
lymphoid organ re-aggregate grafts, we demonstrate
that adult CD34+ adventitial cells are capable of
differentiating into multiple lymphoid stroma-like
subsets including pericyte-, FRC-, MRC-, and FDC-
like cells, the development of which was lymphoid
environment-dependent. These findings extend the
current understanding of lymphoid mesenchymal
cell heterogeneity and highlight a role of the CD34+
adventitia as a potential ubiquitous source of
lymphoid stromal precursors in postnatal tissues.
INTRODUCTION
Lymphoid organs, such as the thymus and lymph nodes (LNs),
play essential roles in the development and functionality of the
adaptive immune system. Accordingly, the thymus is the major
site of T cell developmentwhile LNs support naive T andBcell sur-
vival, facilitate their encounter of antigens, andaid in the regulation
of effector T and B cell responses. While these functions critically
depend on the activity of specialized stromal cell populations,
including cells of mesenchymal origin, our understanding of
mesenchymal subset specialization andontogeny in lymphoid tis-
sues remains limited. InLNs,CD45CD31LNmesenchymalcells
(LNMC) are classically distinguished into podoplanin+ (PDPN+)Celland PDPN subsets. Approximately 60%–70% of PDPN
LNMC express the integrin a7b1 and include contractile pericytes
(Malhotra et al., 2012) while PDPN+ LNMC are distinguished into
three distinct subsets; fibroblastic reticular cells (FRC), follicular
dendritic cells (FDC), and marginal reticular cells (MRC). FRC
wrap around the reticular network of ERTR7+ collagen-rich fibers
in the LN paracortex and contain cells expressing CCR7 ligands
(CCL19 and CCL21), IL-7, cholesterol 25-hydroxylase, and B cell
activating factor (BAFF) and have been implicated in supporting
the homing/migration/survival of T cells (Chang and Turley,
2015; Girard et al., 2012; Link et al., 2007; Yi et al., 2012). In
contrast to FRC, FDC and MRC express high protein levels of
CXCL13 (Katakai et al., 2008). FDC represent a B cell follicle-resi-
dent population, selectively expressing complement receptor
CR-1 (CD35) and CR-2 (CD21), that support B cell follicular
organization and germinal center reactions (Wang et al., 2011)
while MRC are characterized as a population of mucosal vascular
addressin cell adhesion molecule-1 (MAdCAM-1) and receptor
activator of nuclear factor kappa-B ligand (RANKL) expressing
cells of unclear immunological function located underneath the
LN subcapsular sinus (Katakai et al., 2008).
Similar to LNMC, thymic mesenchymal cells (TMC) have been
implicated in a range of immunological processes including sup-
port of early thymus organogenesis (Gordon and Manley, 2011),
regulation of thymic epithelial cell (TEC) homeostasis (Jenkinson
et al., 2007; Sitnik et al., 2012), and thymocyte egress (Zachariah
and Cyster, 2010). TMC are located in the capsule and surround-
ing the vasculature of both thymic cortical and medullary re-
gions, with some displaying pericyte morphology in situ (M€uller
et al., 2008). Several phenotypic markers have been utilized to
identify and/or isolate TMC, including platelet-derived growth
factor receptor a (PDGFRa) and platelet-derived growth factor
receptor b (PDGFRb) (Gray et al., 2007; Odaka, 2009), PDPN (Sit-
nik et al., 2012), and Ly51 (M€uller et al., 2008), however, whether
the TMC compartment consists of functionally distinct subsets
as well as the functional and developmental relationship be-
tween TMC and LNMC subsets remain unknown.
While our knowledge of LNMC and TMC heterogeneity re-
mains limited, even less is known regarding the ontogenic devel-
opment of these cells. During thymus organogenesis, PDGFRa+Reports 14, 2375–2388, March 15, 2016 ª2016 The Authors 2375
mesenchymal cells form an organ capsule around the thymic
epithelial anlagen as it detaches from the third pharyngeal pouch
endoderm at E12.5 (Gordon and Manley, 2011) followed by
migration inside the epithelial core by E13.5 (Mori et al., 2010).
Similarly, during inguinal LN development, PDGFRa+ mesen-
chyme encircles a bulged outgrowth of newly specified
lymphatic endothelium called a lymph sac at E14.5 and subse-
quently infiltrates the endothelial core by E17.5 (Be´ne´zech
et al., 2010). Whether all mature TMC and LNMC subsets can
be derived from a common population of anlage-seeding pro-
genitors and the phenotype of such putative precursor remain
unclear.
In the present study, through comparative analysis of LN and
thymic stroma, we identify CD34+ adventitial cells as a
conserved component of the postnatal thymic and lymph node
vascular niche and demonstrate at the population level that
these cells contain progenitors capable of generating FRC-,
MRC-, and FDC-like cells as well as pericytes. In addition, we
provide data to suggest that lymphoid CD34+ adventitial cells
develop, along with other lymphoid mesenchymal subsets,
from BP-3PDPN+PDGFRb+/a+CD34/loEsam-1 anlage-seed-
ing mesenchymal precursors.
RESULTS
Phenotypic and Global Gene Expression Profiling
Identifies Similar and Distinct Stromal Subsets between
the Thymus and LNs
To gain a better understanding of the heterogeneity and function
of mesenchymal stromal cells in lymphoid organs, we compared
mesenchymal cell subset composition in digested thymic and
pooled inguinal, brachial, and axillary LNs from 6- to 9-week-
old mice by flow cytometry. In both the thymus and LNs, a major
fraction of CD45EpCAMCD31 cells expressed the me-
senchymal cell marker, PDGFRb (hereafter referred to as
thymic and LN mesenchymal cells [TMC and LNMC], respec-
tively) together with a variably detectable population of
CD45EpCAMCD31PDGFRb cells (Figure 1A). Distinct
PDPN+PDGFRa+ and PDPNPDGFRaITGA7+ mesenchymal
subsets have previously been identified in LNs (Malhotra et al.,
2012), and we have recently shown that thymic mesenchymal
cells comprise PDPN+Ly51int and PDPNLy51hi populations (Sit-
nik et al., 2012). Comparative phenotypic analysis revealed that
both LNMC and TMC were composed of a dominant population
of PDPN+PDGFRa+Ly51int and a minor population of
PDPNPDGFRaITGA7+Ly51hi cells (Figure 1B). A substantial
fraction of PDPN+ LNMC, but not TMC, expressed bone marrow
stromal cell antigen-1 (BP-3) (Figure 1B). Similar subset compo-
sition characterized the LNMC compartment in mesenteric LNs
(data not shown). To assess the relationship between TMC and
LNMC subsets, global gene expression analysis was performed
on sorted PDPN and BP-3PDPN+ and BP-3+PDPN+ LNMC as
well as PDPN and PDPN+ TMC (hereafter termed BP-3PDPN+
TMC) from 2-week-old mice by microarray (for sorting strategy
see Figures S1A and S1B). Such analysis confirmed differential
expression at the mRNA level of the phenotypic markers used
to define each population (Figure S1C). Matrix plots of popula-
tion similarity measured by Pearson correlation coefficient2376 Cell Reports 14, 2375–2388, March 15, 2016 ª2016 The Authorconfirmed reproducibility within the triplicate datasets (Fig-
ure S1D) and together with hierarchical clustering and PCA anal-
ysis demonstrated that PDPN TMC most closely resembled
PDPN LNMCwhile BP-3PDPN+ TMCmost closely resembled
BP-3PDPN+ LNMC. BP-3+PDPN+ LNMC were more similar to
BP-3PDPN+ LNMC and TMC than to PDPN LNMC and TMC
(Figures 1C and 1D). Comparison of transcriptional profiles be-
tween PDPN and BP-3PDPN+ TMC and between PDPN
and BP-3PDPN+ LNMC identified 1,760 and 1,498 differentially
expressed genes (>2-fold change [FC]; p value [Benjamini-
Hochberg, pBH] < 0.05; expressed in at least one of compared
subsets) (data not shown). Notably, global changes in gene
expression between PDPN and BP-3PDPN+ TMC correlated
significantly with changes between PDPN and BP-3PDPN+
LNMC; >90% of probe sets that differed >2-fold between
PDPN TMC and BP-3PDPN+ TMCwere similarly up- or down-
regulated between the corresponding subsets in the LNs (probe
sets expressed in at least one TMC and LNMC subset; CV < 0.5
for all subsets) (Figure 1E).
PDPN and BP-3PDPN+ Cells Form Specialized
Components of the Vascular Niche
Immunohistochemical analysis has previously indicated that LN
FDC, MRC, and T-zone FRC express BP-3 (Katakai et al.,
2008; Link et al., 2007). We thus determined whether such pop-
ulations were present within BP-3+PDPN+ LNMC. A fraction of
BP-3+PDPN+ LNMC, but not BP-3PDPN+ LNMC or TMC,
expressed intracellular CCL21 protein, and a subset of
BP-3+PDPN+ LNMC expressed MAdCAM-1. BP-3+PDPN+
LNMC also demonstrated the highest mRNA levels of genes
associated with FRC and MRC (Figures 2A, 2B, and S2A).
Further, staining for the FDC markers, CR-1 (CD21) and CR-2
(CD35), demonstrated that CR1/2+PDPN+ FDC were BP-3+ and
PDGFRb/lo (Figure 2C). Collectively, these results demonstrate
that BP-3+PDPN+ LNMC include CCL21+ FRC, MRC, and FDC,
and that these subsets are absent from steady-state thymus.
Gene sets associated with vascular smooth muscle cell
(VSMC) contractility (Malhotra et al., 2012) and pericyte identity
(Armulik et al., 2011) were highly expressed by PDPN compared
to PDPN+ TMC and LNMC (Figure 2D), which correlated with the
specific detection of high levels of a-smoothmuscle actin, aSMA
in a proportion of these cells (Figure 2E). Thus, PDPN TMC and
LNMC appear to contain both contractile and non-contractile
pericytes. PDPN TMC and the majority of PDPN LNMC, but
not PDPN+, populations also expressed endothelial cell-selec-
tive adhesion molecule-1, Esam-1 (Figures 2D and 2F). Analysis
of the remaining BP-3PDPN+ LNMC and TMC subsets demon-
strated that these cells expressed highest levels of CD34 (Fig-
ure 2G), a sialomucin expressed by mesenchymal adventitial
cells in human arteries and veins (Corselli et al., 2012).
To assess the localization of BP-3PDPN+CD34+ and PDPN
LNMC and TMC, immunohistochemical staining was performed
on thymic and LN sections. PDGFRb+/a (PDPN) TMC were
detected in direct association with CD31+ vascular endothelium
of capillaries (Figures S2B and S2C, arrowheads) as well as arte-
rioles (data not shown) and venules within the thymic cortex,
cortico-medullary junction (CMJ), and medulla (Figure 2H, ar-
rowheads). In agreement with previously reported distributions
Figure 1. Comparison of Lymph Node and Thymic Mesenchymal Cell Subsets
(A and B) Identification (A) and phenotype (B) of PDGFRb+ mesenchymal cells from pooled inguinal, brachial, and axillary LNs (LNMC) and thymus (TMC) from
6- to 9-week-old mice. (A) Lineage; CD45, Ter119, CD11b, CD11c, NK1.1, Gr-1, B220. Numbers are percentage of cells within indicated gates or mean per-
centage (SD) within PDPN+ cells (BP-3). (B) Data are from one representative experiment of three (PDGFRa, ITGA7, Ly51) or ten (BP-3) performed using pooled
cells from one to six mice per experiment.
(C–E) Comparative gene expression analysis of LNMC and TMC subsets from 2-week-old mice. For sorting strategy see Figure S1. (C) Hierarchical clustering of
the 4,523 genes with greatest changes in gene expression. (D) Principal component (PC) analysis. Numbers in brackets represent the percentage of total
variability accounted for by each PC. (E) Scatter plot of the fold changes in gene expression between PDPN and BP3PDPN+ TMC (x axis) and LNMC (y axis).
Each dot represents one probe set. Probe sets downregulated or upregulated >2-fold in PDPN compared to BP3PDPN+ TMC are shown in blue and red,
respectively. The dashed gray line represents the diagonal and the black solid line depicts the regression line fitted through all data points. R value indicates the
Pearson correlation coefficient between the two datasets. Numbers indicate the total number of probes of that color within indicated quadrants.
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Figure 2. PDPN and BP3PDPN+ TMC and LNMC Represent Specialized Components of the Vascular Niche
(A–G, L) Heatmaps of expression values of selected genes expressed by LNMC and TMC subsets. Data are log2 transformed and row normalized. Numbers in
brackets are fold difference in the expression of the indicated genes between BP3+PDPN+ and BP3PDPN+ LNMC. (A and B) PDGFRb+PDPN+ or (C)
(legend continued on next page)
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of ITGA7+ LNMC (Malhotra et al., 2012), PDGFRb+/a (PDPN)
LNMC were found in direct contact with the CD31+ endothelium
of cortical and medullary vessels as well as lining the lymphatic
endothelium of the subcapsular sinus (Figure 2I; data not
shown). Thus, the distribution of PDGFRb+/a (PDPN) TMC
and LNMC fitted with their transcriptional identification as peri-
cytes. In contrast, CD34 expressing PDGFRb+/a+ (PDPN+)
mesenchymal cells were detected in the thymic and LN capsule
(data not shown) and as outer layers surrounding PDGFRb+/a
(PDPN) cells and CD31+ endothelium of larger blood vessels
throughout the thymus and in the LNmedulla (Figures 2H–2K, ar-
rows). Similarly, a population of PDGFRb+/a+CD34+ mesen-
chymal cells surrounded central arterioles in splenic white pulp
areas (Figures S2D and S2E). Notably, PDPN LNMC and
TMC selectively expressed the endothelial cell regulator angio-
poietin-1 (Fagiani and Christofori, 2013) (Figure 2L) while
BP-3PDPN+ LNMC and TMC were major sources of VEGF,
IGF, and FGF family members with vasculogenic/angiogenic po-
tential (Contois et al., 2012; Das et al., 2013; Lee et al., 2000; Lo-
hela et al., 2009; Oh et al., 2012; Presta et al., 2005; Shigematsu
et al., 1999; Zhang et al., 2012) (Figures 2L and 2M). Further,
BP-3PDPN+ TMC, but not PDPN TMC, expressed mRNA for
IGF-1, IGF-2, FGF-7, and FGF-10, which have been implicated
as mesenchymal-dependent regulators of TEC growth (Jenkin-
son et al., 2007; Revest et al., 2001) (Figures 2L and 2M). To
assess the role of lymphocytes in the generation and/or mainte-
nance of lymphoid mesenchymal cells, the TMC and LMNC
subset composition of Rag1/ mice was assessed (Figures
S2F–S2L). BP3PDPN+ and PDPN TMC were found at normal
ratios in Rag1/mice (Figures S2F–S2H). Among the three ma-
jor LNMC subsets, Rag1/ mice displayed a marked decrease
in the proportion of BP-3+PDPN+ LNMC, a slight but significant
increase in BP-3PDPN+CD34+ LNMC, and a slight decrease
in PDPN LNMC compared with control mice (Figures S2I and
S2J). Further remaining BP-3+PDPN+ LNMC inRag1/mice ex-
pressed reduced levels of BP3 as well as intracellular CCL21
(Figures S2J–S2L).
Adult Adipose-Derived CD34+ Adventitial Cells Can
Differentiate into Multiple Lymphoid Stroma-like
Subsets
We next determined whether BP-3PDPN+PDGFRb+/a+CD34+
cells were also present in adventitial vascular niches of murine
extra-lymphoid tissues. Indeed, PDGFRa+CD34+ cells were
observed surrounding aSMA+ vascular smooth muscle cell
(VSMC)-containing tunica media of the aorta as well as withinCD45EpCAMCD31PDPN+ LNMC and TMC from 6- to 9-week-old mice were
representative of six (A), five (B), or three (C) experiments using pooled cells from o
aSMA and (F) Esam-1 expression by LNMC and TMC from 6- to 7-week-old mice
from two to six mice per experiment. (G) CD34 expression by PDPN+ LNMC and
using pooled cells from two to five (LNMC) or one to two (TMC) mice per experim
mean percentage (SD) of Esam-1+ cells among PDPN TMC. (A–G) LNMC; pool
(H and I) In situ localization of PDPN (PDGFRb+/a; arrowheads) and PDPN+ (P
medullary area of the inguinal LN. (J and K) In situ localization of BP3PDPN+CD
and (K) medullary area of the inguinal LN. Sections from 2-week-old mice (H and I
(H, I, K) three mice. Single color stains are shown on the right. See also Figure S
(M) Real-time PCR analysis of the indicated genes in PDPN and PDPN+ TMC fro
cells from eight mice per experiment. *p < 0.05 and ***p < 0.001 (unpaired two-t
Cellthe vascular niche of adipose tissue and intestine (Figures 3A
and 3B, data not shown). Flow cytometry analysis of
CD45CD31 fractions in digested adipose tissue demon-
strated, as in lymphoid tissues, that PDGFRa+CD34+ adventitial
cells expressed PDGFRb, PDPN, but not BP-3, and they
represented a distinct compartment from PDGFRb+/
aITGA7+Esam-1+ cells (Figures 3C and 3D). Since purified adult
human CD34+ adventitial cells have previously been reported to
contain clonal progenitors with tri-lineage adipogenic, chondro-
genic, and osteogenic potential in vitro (Corselli et al., 2012), we
next assessed whether murine CD34+ adventitial cells could
generate lymphoid stromal subsets. Flow cytometry analysis of
adipose tissue CD34+ adventitial cells demonstrated that these
cells were heterogeneous in their expression of ICAM-1 (Fig-
ure 3D), a marker induced on PDGFRa+PDPN+ LNMC during
LN ontogeny (Be´ne´zech et al., 2010). We thus sorted EYFP+
ICAM-1/lo CD34+ adventitial cells from digested subcutaneous
fat of 2- to 5-month-old Eyfp-Rosa26 mice (for gating strategy
see Figure S3A) and re-aggregated these cells with single cell
suspensions obtained from wild-type E19 mesenteric LN or
E15 thymus, and 36–48 hr later, resulting re-aggregate LN organ
cultures (RLOC) and re-aggregate thymus organ cultures (RTOC)
were engrafted under the kidney capsule of wild-type recipient
mice (Figure 3E). Consistent with previous studies (Be´ne´zech
et al., 2012; Wong et al., 2014), 3 weeks after grafting, RLOC
had adopted a LN structure containing populations of mature T
and B cells segregated into T and B cell zones (Figures S3B
and S3C) and with all LNMC subsets (Figure 2) present within
the YFP stromal cell compartment (Figures S3D and S3E). In
contrast, RTOC contained CD4+CD8+ double-positive (DP) as
well as CD8+ and CD4+ single-positive (SP) thymocytes (Fig-
ure S3C), and the YFP stromal cell compartment of RTOC
grafts was composed of subsets characteristic of the thymic
stroma (Figures S3D and S3E). EYFP+ cells in RLOC grafts could
be divided into populations of PDPNPDGFRaITGA7+ and
PDPN+PDGFRa+ cells, the latter subset consisting of a BP-3
and a BP-3+ fraction (Figures 3F, 3G, and S3F) with
EYFP+BP-3+PDPN+ cells containing populations of MAdCAM-
1+ and CR1/2+ cells (Figures 3F and 3G). Consistent with the dis-
tribution of ITGA7+ pericytes and CD34+ adventitial cells in
nascent LNs, EYFP+ITGA7+ cells were found both inside and
outside of the paracortical areas in the grafts in intimate associ-
ation with CD31+ blood vessels (Figure 3H), while EYFP+CD34+
cells integrated into the adventitial layer of larger blood vessels,
in areas surrounding the paracortex, and in the capsule (Fig-
ure 3I). EYFP+CR1/2+ cells were selectively identified inside Banalyzed for expression of (A) CCL21, (B) MAdCAM-1, and (C) CR1/2. Data are
ne to sixmice per experiment. rabIgG, rabbit IgG control. See also Figure S2. (E)
. Data are representative of two (E) or three (F) experiments using pooled cells
TMC from 6- to 8-week-old mice. Data are representative of five experiments
ent. (A–C, E, G) Numbers are percentage of cells within indicated gates or (F)
ed inguinal, axillary, and brachial LNs.
DGFRb+/a+; arrows) mesenchymal cells in (H) the CMJ of the thymus and (I)
34+ (PDGFRa+CD34+; arrows) mesenchymal cells in (J) the CMJ of the thymus
) or 7-week-old mice (J and K). Results are representative stains from (J) two or
2.
m 2-week-old mice. Data are mean (SD) from three experiments using pooled
ailed Student’s test).
Reports 14, 2375–2388, March 15, 2016 ª2016 The Authors 2379
Figure 3. Adult Adipose-Derived CD34+ Adventitial Cells Are Capable of Differentiating into Multiple Lymphoid Stromal-like Subsets
(A and B) Cryosections of the aorta (A) and inguinal fat pad (B) from an 11-week-old mouse were stained with indicated antibodies. Single color stains are shown
on the right. Examples of PDGFRa+CD34+ adventitial cells (arrows).
(C and D) Phenotype of PDGFRb+ (C) or PDPN+CD34+ (D) CD45CD31 adipose tissue mesenchymal cells isolated from subcutaneous fat of 5- to 12-week-old
mice. Numbers are percentage of cells within indicated gates. Representative plots from three experiments using pooled cells from (C) one to two or (D) one to six
mice/experiment.
(E–G) RLOC and RTOC were spiked with EYFP+ ICAM-1/lo BP3PDPN+CD34+ Esam-1 adventitial cells from 2- to 5-month-old Eyfp-Rosa26 mice (for sorting
strategy see Figure S3A), transplanted under the kidney capsule of 7- to 11-week-old wild-type mice and EYFP+ cells in the grafts analyzed 3 to 4 weeks later.
(C–E) ATMC, adipose tissue mesenchymal cells. (F) Representative plots pre-gated on indicated populations and (G) percentage of indicated EYFP+ subsets. (G)
Percentage of EYFP+ PDPNITGA7+, MAdCAM-1+, and CR1/2+ cells was normalized to the percentage of corresponding subsets among EYFP
(legend continued on next page)
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cell rich areas of the paracortex (Figure 3J), and consistent with
the detection of EYFP+BP3+MAdCAM-1CR1/2 cells by flow
cytometry, EYFP+ cells were also found associated with
ERTR7+ reticular fibers in T cell-rich areas (Figure 3K). In marked
contrast to RLOC grafts, EYFP+ ICAM-1/lo CD34+ adventitial
cells in RTOC grafts differentiated into PDPNITGA7+ cells but
failed to differentiate into BP-3+PDPN+ subsets (Figures 3F
and 3G). Collectively, these results indicate that adult
ICAM-1/lo CD34+ adventitial cells contain precursors capable
of giving rise to pericyte-, FRC-, MRC-, and FDC-like cells, and
the differentiation capacity of these cells is dependent on the
environmental context.CD34+ Thymic Adventitial Cells Contain Precursors with
Lymphoid Stroma-like Subset Potential
To assess whether lymphoid-resident CD34+ adventitial cells
also display lymphoid stromal subset-like potential, we per-
formed similar experiments with postnatal thymic BP3PDPN+
cells (all of which express CD34; Figure 2G; data not shown).
Analysis of Sox10Cre.RosaEyfp mice, in which neural crest
(NC)-derived cells are indelibly marked with EYFP expression
(M€uller et al., 2008), demonstrated that both adult PDPN and
BP-3PDPN+ TMC were of NC-origin (Figures S4A and S4B).
RTOC grafts were thus spiked with EYFP+BP-3PDPN+ or
EYFP+PDPNEsam-1+ TMC from 2- to 3-week-old Sox10Cre.R-
osaEyfpmice (Figure 4A), a time point whenmaximal numbers of
EYFP+PDPNEsam-1+ TMC could be obtained (Figure S4C).
Postnatal EYFP+BP-3PDPN+ TMC generated PDPNEsam-1+
cells (Figures 4B and 4C) but failed to generate BP-3+PDPN+
cells in five of five independently generated RTOC grafts (Fig-
ure 4C). Conversely, EYFP+PDPNEsam-1+ TMC failed to differ-
entiate into PDPN+ cells (Figures 4B and 4C) and EYFP+ cell
recovery in those grafts was diminished (data not shown). We
next tracked the expression of ICAM-1 by PDPN+ TMC from
E14.5 until 9 weeks of age (Figure 4D). At E14.5, PDPN+ TMC
were uniformly ICAM-1/lo, however, by birth, a subset of cells
expressing an elevated level of ICAM-1 (hereafter called
ICAM-1hi) had emerged and the ICAM-1hi to ICAM-1/lo ratio
within the PDPN+ TMCcompartment aswell as the surface levels
of ICAM-1 expressed by ICAM-1hi cells continued to increase
until 9 weeks (Figure 4D). These results suggested, similar to
LNs (Be´ne´zech et al., 2010), a maturation pathway for PDPN+
TMC involving upregulation of ICAM-1 by ICAM-1/lo precur-
sors. To determine whether postnatal ICAM-1/lo and ICAM-1hi
BP-3PDPN+ thymic adventitial cells were capable of gener-
ating pericyte-like cells, EYFP+ ICAM-1/lo and ICAM-1hi
BP-3PDPN+ TMC were isolated from 5-week-old Sox10Cre.R-
osaEyfp mice and used in RTOC grafting experiments (Figures
4A, 4E, and 4F). EYFP+PDPN+ cells in grafts spiked with
ICAM-1/lo and ICAM-1hi BP-3PDPN+ TMC were ICAM-1hi,
suggesting that postnatal ICAM-1/lo BP-3PDPN+ TMCcontainCD45EpCAMCD31 (PDPNITGA7+) or CD45EpCAMCD31PDPN+BP-3+
represents data from one graft. Horizontal line, mean (SD).
(H–K) In situ localization of (H) EYFP+ITGA7+ pericyte-like cells (arrows), (I) EYFP+
and (K) EYFP+ERTR7+ T-zone FRC-like cells (arrows) in transplanted RLOC. Re
stains are shown on the right.
See also Figure S3.
Cellprecursors of ICAM-1hi BP-3PDPN+ TMC (Figure 4E). Both
populations were capable of differentiating into PDPNEsam-1+
cells, although ICAM-1/lo BP-3PDPN+ TMC appeared to do so
less efficiently (Figures 4E and 4F). Finally, EYFP+ ICAM-1/lo
BP-3PDPN+CD34+ thymic adventitial cells sorted from
9-week-old Sox10Cre.RosaEyfp or 5- to 6-week-old Eyfp-
Rosa26 mice gave rise in two out of five RLOC grafts to
BP-3+PDPN+ cells containing MAdCAM-1+ cells at ratios similar
to EYFP+ cells in adipose-derived adventitial cell-spiked RLOC
(Figures 3G, 4G, and 4H). Together, these data suggest that
CD34+ adventitial cells of adult lymphoid tissues also include
progenitors with lymphoid stromal subset-like potential.PDPN and BP-3PDPN+CD34+ TMC Develop from a
Common Anlage-Seeding Population
To gain insight into the ontogeny of Esam-1+PDPN,
BP-3PDPN+CD34+ LNMC/TMC, and BP-3+PDPN+ LNMC, we
assessed the population dynamics of these subsets during
embryonic development. At E13.5, the PDGFRb+ TMC
compartment was composed almost entirely of
PDPN+PDGFRa+CD34/loEsam-1 cells (Figure 5A). By E14.5,
all TMC remained CD34/lo and a small population of
PDPN+PDGFRaEsam-1+ cells had emerged. By E18.5,
PDPN+PDGFRa+ cells expressed intermediate levels of CD34,
while PDPN expression by the PDGFRaEsam-1+ fraction
decreased (Figure 5A). By 7 days post-birth, PDPN+PDGFRa+
cells were CD34+ while PDGFRaEsam-1+ cells were PDPN
(Figure 5A). Similar to embryonic TMC, E16.5 LNMC were all
BP-3CD34/lo and composed of a major PDPN+PDGFRa+
and a minor PDGFRaEsam-1+ population (Figure 5B). Notably,
the latter subset contained a PDPN+ fraction, not present in age-
matched inguinal fat pad (Figure 5C), which by 1 week post-birth
had downregulated PDPN (data not shown). By E17.5, all LNMC
remained CD34/lo and a subset of BP-3+PDPN+PDGFRa+ cells
emerged, the proportion of which continued to increase until
1 week post-birth (Figure 5B). At E18.5, the remaining
BP-3PDPN+PDGFRa+ cells expressed intermediate levels of
CD34 (Figure 5B). By 1 week post-birth, a distinct population
of BP-3PDPN+PDGFRa+CD34+ cells had emerged (Figure 5B).
Further analysis of LNMC subsets in adult Sox10Cre.RosaEyfp
mice demonstrated that PDPN, BP-3PDPN+, and
BP-3+PDPN+mesenchymal cells in cervical LNs are of NC-origin
while similar subsets in LNs located in the trunk were EYFP and
thus not of NC origin (Figure S5). Collectively, these results sug-
gested that Esam-1+PDPN pericytes in both the thymus and
LNs arise via a PDPN+PDGFRa intermediate from
BP-3PDPN+PDGFRb+/a+CD34/lo cells that subsequently up-
regulate CD34. To assess this possibility, E13.5 thymic lobes
from Eyfp-Rosa26 mice (Srinivas et al., 2001) were grafted under
the kidney capsule of wild-type recipient mice, and the pheno-
type of EYFP+ cells was assessed in the grafts 12 days later(MAdCAM-1+ and CR1/2+) graft-derived mesenchymal cells. Each symbol
CD34+ adventitial-like cells (arrows), (J) EYFP+CR1/2+ FDC-like cells (arrows),
sults are representative stains from three individual RLOC grafts. Single color
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Figure 4. Postnatal Thymus-Derived CD34+ Adventitial Cells Contain Precursors with Lymphoid Stroma-like Subset Potential
(A–C, E, F) RTOC were spiked with EYFP+ TMC from 2.5- to 3-week-old (A–C) or 2.5- or 5-week-old (E and F) Sox10Cre.Rosa26Eyfp mice as indicated,
transplanted under the kidney capsule of 7- to 10-week-old wild-typemice and EYFP+ cells in the grafts analyzed 12–13 days later. (B and E) Representative plots
pre-gated on indicated populations. (C and F) Percentage of indicated EYFP+ subsets. (F) Data are normalized to the percentage of PDPNEsam-1+ cells among
EYFPCD45EpCAMCD31 mesenchymal cells in the graft.
(D) ICAM-1 expression by PDPN+PDGFRa+ TMC at indicated time points. Dotted vertical line shows the mean fluorescence intensity (MFI) of the isotype control
and the dashed vertical line separates ICAM-1/lo and ICAM-1hi subsets. All time-points were analyzed on the same day. Data are representative results from
three biological replicates per time-point using pooled cells from three (E14.5, newborn) or one (1 week, 4.5 weeks, 9 weeks) mice/replicate.
(G andH) RLOCwere spiked with EYFP+ ICAM-1/lo BP3PDPN+CD34+Esam-1 TMC from 9-week-old Sox10Cre.Rosa26Eyfp or 5- to 6-week-old Eyfp-Rosa26
mice, transplanted under the kidney capsule of 5- to 9-week-old wild-type mice and EYFP+ cells in the grafts analyzed 3–4 weeks later. (H) Representative plots
pre-gated on total EYFP+ or EYFP CD45EpCAMCD31 cells and percentage and number of indicated EYFP+ subsets. Percentage of EYFP+MAdCAM-1+
cells was normalized to the percentage of MAdCAM-1+ cells among EYFP CD45EpCAMCD31PDPN+BP-3+ graft-derived mesenchymal cells. (B, E, H)
Numbers in the plots are percentage of cells within indicated gates, and (C, F, H) each bar or symbol represents data from a single graft. (H) Filled symbols of the
same color denote the same graft in different graphs.
See also Figure S4.
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(Figure 5D). The PDGFRb+ mesenchymal compartment in the
grafts consisted mainly of EYFP+ Esam-1+PDPN and
PDPN+CD34+ cells (Figure 5E). To directly assess whether
Esam-1+PDPN TMCcould be generated fromPDPN+PDGFRa+
embryonic thymic mesenchyme, EYFP+ PDPN+PDGFRa+Esam-
1 mesenchymal cells were sorted from E14.5 thymuses of
Sox10Cre.RosaEyfp mice and re-aggregated with embryonic
TEC and thymocytes. The RTOC were then grafted under the
kidney capsule of wild-type recipient mice and the phenotype
of EYFP+ cells in the grafts was assessed after 10 days (Fig-
ure 5F). Consistent with results from E13.5 thymus transplanta-
tion, a large proportion of EYFP+ cells recovered from the grafts
were PDPNPDGFRaEsam-1+ demonstrating the capacity of
embryonic PDPN+PDGFRb+/a+CD34/loEsam-1 TMC to give
rise to Esam-1+PDPN cells (Figures 5G and 5H). We were
unable to perform similar studies with embryonic
BP-3PDPN+PDGFRb+/a+CD34/loEsam-1 LNMC due to
limited cell numbers. Further, when Eyfp-Rosa26 E16.5 inguinal
LN anlagenwas grafted under the kidney capsule of wild-type re-
cipients only 3 out of 26 grafts recovered contained T andB cells,
consistent with the inability of E15.5 inguinal LN to generate
functional LN grafts due to insufficient number of CD3CD4+
inducer cells (White et al., 2007). Only one of these contained
sufficient LNMC for analysis, and the CD45CD31 compart-
ment in this graft consisted almost exclusively of EYFP+ cells
and contained PDPNITGA7+, BP-3PDPN+CD34+ as well as
BP-3+PDPN+ cells including CCL21+ FRC-like cells (data not
shown). Collectively, these results demonstrate that PDPN
and BP-3PDPN+CD34+ TMC originate from a common
PDPN+PDGFRb+/a+CD34/loEsam-1 subset of anlage-seeding
precursors and suggest that LNMC subsetsmay originate from a
phenotypically similar BP-3 precursor population.
LTbR Signaling Is Required for the Maturation/
Maintenance of BP-3PDPN+ TMC
Given previous evidence implicating a role for LTbR-signaling in
the differentiation of FRC, MRC, and FDC (Chai et al., 2013; Ka-
takai et al., 2008; Krautler et al., 2012), we finally sought to assess
the role of the LTbR pathway in the development of Esam-
1+PDPN and BP3PDPN+ TMC, all of which express LTbR (Fig-
ure 6A). Consistent with a previously reported reduction in
PDGFRa+ TMC in Lta/ and Ltb/ mice (Gray et al., 2007),
Ltbr/ mice displayed a marked reduction in ICAM-1hiVCAM-
1+PDPN+ TMC while ICAM-1hiVCAM-1, ICAM-1/lo PDPN+,
and Esam-1+PDPN TMC compartments were unaffected (Fig-
ures 6B–6E). ICAM-1hiVCAM-1 PDPN+ TMC from Ltbr/
mice also displayed reduced ICAM-1 expression indicative of a
maturation defect (Figure 6F). Together, these results suggest
that LTbR signaling is required for the maturation of the CD34+
TMC compartment. ICAM-1hiVCAM-1+PDPN+ TMC and ICAM-
1 expression on these cells was unaffected inRag1/mice (Fig-
ure 6G), indicating that DP and SP thymocytes were not a key
source of LTbR ligands regulating CD34+ TMC homeostasis.
DISCUSSION
Studies assessing the phenotype and heterogeneity of
lymphoid mesenchymal cell compartments have relied heavilyCellon in situ immunohistochemical analysis, and our understand-
ing of the subset composition and specialized function of
LNMC and TMC remains far from complete. Here, by
combining detailed flow cytometry and global gene expression
analysis in combination with in situ localization studies, we per-
formed a comprehensive analysis of the mesenchymal subset
composition in LNs and thymus that we believe provides an
important framework for assessing mesenchymal functional
specialization and for the interpretation of prior genetic reporter
and Cre-mediated deletion strategies. Prior flow cytometry
analysis of LNMC has suggested that PDPN+ LNMC contain
MAdCAM-1+ MRC, CR1/CR2+ FDC and MAdCAM-1CR1/
CR2 FRC (Malhotra et al., 2012). Consistent with these find-
ings, we demonstrate that all three subsets are present within
the PDPN+ fraction of LNMC, with FRC positively identified
by their expression of intracellular CCL21, and these popula-
tions can be collectively distinguished by their co-expression
of BP-3. While BP-3+PDPN+ cells were absent from the TMC
compartment, we identified two mesenchymal subsets com-
mon to both the thymus and LNs; a PDPNPDGFRb+/
aEsam-1+ITGA7+ mesenchymal subset containing contractile
and non-contractile pericytes and a population of
BP-3PDPN+PDGFRb+/a+CD34+ mesenchymal cells. Both
subsets localized within distinct locations in the vascular niche
with the former cells, consistent with their pericyte-associated
gene expression signature, intimately associating with the
vascular endothelium and the latter forming the adventitia sur-
rounding these cells. Previous studies have demonstrated that
CD34 is expressed by adventitial cells within human adipose
tissue, skeletal muscle, pancreas, and lung (Corselli et al.,
2012; Lin et al., 2008) as well as murine aorta (Hu et al.,
2004), and we demonstrate here that CD34+ adventitial cells
are also present within murine adipose tissue and small intes-
tine indicating that CD34 may represent a conserved marker
to identify adventitial cells within the vascular niche. Notably,
lymphoid tissue BP-3PDPN+CD34+ adventitial mesenchymal
cells and PDPNITGA7+ pericytes expressed a distinct array
of endothelial regulatory and angiogenic factors suggesting
that these subsets play partially non-redundant roles in sup-
porting vascular endothelial cell homeostasis in these tissues.
Utilizing kidney capsule transplantation of spiked lymphoid or-
gan re-aggregates, we provide evidence that adult CD34+
adventitial cells at a population level are capable of giving rise
to multiple lymphoid stroma-like subsets. These results are
consistent with prior observations that adult adipose-derived
PDGFRa+PDPN+ stromal cells generate MAdCAM-1+ progeny
as well as ERTR7+ FRC-like networks in transplanted LN re-
aggregate grafts (Be´ne´zech et al., 2012), and adult PDGFRb+ ad-
ipose-derived cells give rise to CR1/CR2+ FDC-like cells
following grafting and immunization (Krautler et al., 2012).
Phenotypic and functional equivalents of LNMC subsets arise
ectopically in multiple adult organs as part of organized tertiary
lymphoid organs (TLO) that develop in association with chronic
inflammation and cancer (Neyt et al., 2012). While the identity
of the mesenchymal TLO precursors remains unclear, our find-
ings suggest that CD34+ adventitial cells may be a potential
source of TLO stromal progenitors in extra-lymphoid tissues.
Indeed, lymphoid neo-genesis is observed in association withReports 14, 2375–2388, March 15, 2016 ª2016 The Authors 2383
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blood vessels in lungs of patients with idiopathic pulmonary hy-
pertension (Perros et al., 2012) and within the adventitia of
atherosclerotic plague-burdened aorta of aged Apoe/ mice
(Gra¨bner et al., 2009).
While pericyte-like cells were generated in transplanted RTOC
and RLOC, only the latter supported the development of B-zone
CR1/2+ FDC-like, T-zone ERTR7+ FRC-like, and MAdCAM-1+
MRC-like BP3+PDPN+ subsets. Collectively, these results sug-
gest that differences in thymic and LN mesenchymal cell subset
composition are not a result of cell intrinsic properties of seeding
stromal populations but rather governed by tissue-specific sig-
nals mesenchymal cells receive within their respective environ-
ments. While the tissue-derived signals that allow BP-3+PDPN+
mesenchymal cell subset generation in LNs, but not thymus,
remain to be fully elucidated, we demonstrate that Rag-1/
mice have reduced proportions of BP-3+PDPN+ LNMC and
that remaining BP-3+PDPN+ LNMC in these mice display
reduced expression of BP-3 and CCL21. Consistent with these
findings, SCID and/or Rag-2/ mice have previously been
shown to lack FDC and to display a marked reduction in
PDPN+MAdCAM-1+ LNMC (Fletcher et al., 2011; Gonzalez
et al., 1998). These results also suggest that a lack of a particular
T and/or B cell subset cannot alone account for the absence of
BP-3+PDPN+ cells in the thymus and in RTOC grafts. We spec-
ulate that the differential generation of BP-3+PDPN+ cells in
these organs could be additionally promoted by the presence
of specific inhibitory factors. In this regard, it is of interest
to note that progressive reduction in TEC, as occurs in FoxN1-
Cre.Dicerfl/fl mice (Zuklys et al., 2012), leads to thymic induction
of a LN-like environment including generation of CD21+ FDC-like
and ERTR7+ FRC-like mesenchymal networks in areas devoid
of TEC.
Our studies on the kinetics of embryonic lymphoid tissue
development suggest that CD34+ adventitial cells arise in the
thymus in the late embryo and in the LNs postnatally. Further,
we demonstrate in the thymus that these cells develop, along
with pericytes, from PDPN+PDGFRb+/a+CD34/lo anlage-seed-
ing mesenchymal precursors. Pericytes have been shown to
originate from both mesoderm and neural crest (Armulik et al.,
2011), however, the developmental relationship of pericytes to
other mesenchymal populations has remained unclear. Our find-
ings suggest that lymphoid-associated pericytes do not arise
from CD34+ adventitia during ontogeny but that the latter cells
may contribute to pericyte turnover and homeostasis in post-
natal tissues.Figure 5. PDPN and BP-3PDPN+CD34+ TMC Derive from a Common
(A–C) PDGFRb+ thymic (A), inguinal LN (B and C), and inguinal fat pad (C) mesench
in the plots are percentage of cells in each quadrant. (A) Data are representative pl
experiment. (B) Data are representative of pooled cells from five (day 7), six (E17
pooled cells from six to ninemice per experiment. (C) Data are representative of po
from individual mice or pooled inguinal LN cells from six to nine mice per experim
(D and E) Thymic lobes from E13.5 Eyfp-Rosa26 mice were transplanted under
chymal cells in the grafts analyzed 12 days later. (E) Representative plot and pe
(PDPN+) mesenchymal populations from three individual grafts. Numbers in the
(F–H) RTOC were spiked with EYFP+ TMC from E14.5 Sox10Cre.RosaEyfpmice
typemice and EYFP+ cells in the grafts analyzed 10 days later. (G) Representative
grafts. (G) Numbers in the plots are percentage of cells within each gate. (H) Eac
See also Figure S5.
CellIn conclusion, our comprehensive assessment of lymphoid
stromal cell functional heterogeneity and ontogeny led to the
identification of lymphoid CD34+ cells as a common constituent
of the vascular niche, distinct from pericytes, FRC, MRC, and
FDC and showed that CD34+ adventitial cells at the population
level display lymphoid stroma-like progenitor potential. While
future experiments are required to assess the multi-potent pro-
genitor potential of individual CD34+ adventitial cells, we believe
our findings provide an important framework for future studies
assessing stromal subset functionality and ontogeny not only
during the initiation of adaptive immunity but also in pathological
settings such as cancer, obesity, vascular disease, and chronic
inflammation.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 mice, Rag1/ mice, Eyfp-Rosa26 mice (Srinivas et al., 2001), and
Sox10Cre.Rosa26Eyfp mice (M€uller et al., 2008) were bred and maintained
at the Biomedical Centre Animal Facility (Lund University, Lund, Sweden).
Ltbr/ and Ltbr+/(+/) mice were housed in the Biomedical Services Unit at
the University of Birmingham, UK. Day of vaginal plug detection was desig-
nated as day 0.5 of gestation. All animal procedures were approved by the
Lund/Malmo¨ Animal Ethics Committee.
Flow Cytometry and Cell Sorting
Flow cytometry was performed with antibodies (Table S1) according to
standard procedures. Dead cells (identified as propidium iodide+ or using
LIVE/DEAD Violet Fixable Dead Cell Staining Kit; both from Invitrogen)
and cell aggregates (identified on FSC-A versus FSC-W scatter plots)
were excluded from all analyses. Data acquisition was performed on a
FACSAria or LSRII (BD Biosciences) and analyzed using FlowJo software
(Tree Star). For analysis of aSMA and CCL21 expression, surface-labeled
cell suspensions were fixed and permeabilized using the Foxp3 Staining
Buffer Set (eBioscience) or 4% PFA and 0.1% saponin, respectively, fol-
lowed by staining with FITC-anti-aSMA antibody or consecutive incubations
with rabbit anti-CCL21 antibody and Alexa Fluor 647-goat anti-rabbit IgG
secondary antibody. Sorting was performed on a FACSAria (BD
Biosciences).
Immunofluorescence Staining
Cryosections (7–8 mm) from snap frozen or paraformaldehyde-fixated tissues
were stained with antibodies (Table S2) using standard protocols and as
detailed in the Supplemental Experimental Procedures. EYFP expressing cells
were identified following incubation with a polyclonal chicken anti-GFP anti-
body (Aves Labs) and Alexa488 conjugated donkey anti-chicken secondary
antibody (Jackson ImmunoResearch). Images were acquired with LSM 750
confocal microscope and analyzed using ZEN software (both from Carl Zeiss
MicroImaging).Anlage-Seeding Population
ymal cell subset composition was assessed at indicated time points. Numbers
ots from three experiments using pooled thymic cells from two to threemice per
.5), or eight (E16.5) mice or representative of three experiments (E18.5) using
oled cells from five to six mice (E17.5) or of two experiments using fat pad cells
ent.
the kidney capsule of 7-week-old wild-type recipients and PDGFRb+ mesen-
rcentage of EYFP+ cells among PDPNEsam-1+ (PDPN) and PDPN+CD34+
plots are percentage of cells within indicated gates.
as indicated, transplanted under the kidney capsule of 7- to 10-week-old wild-
plots and (H) percentage of PDPNEsam-1+ cells among total EYFP+ cells in the
h bar represents data from an individual graft.
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Figure 6. LTbR Signaling Plays a Role in the Maturation/Maintenance of BP-3PDPN+ TMC
(A) PDPN and PDPN+ TMC from 2-week-old mice were analyzed for the expression of LTbR by flow cytometry. Shown are histogram plots representative of two
biological replicates using pooled cells from two mice/replicate.
(B–F) Phenotype of PDGFRb+ (B andC) or PDGFRb+PDPN+ (D and F) mesenchymal subsets in the thymus of 5-week-old Ltbr/ or littermate control mice. (B and
D) Representative plots with numbers representing percentage of cells within indicated gates. (C and E) Cell numbers (mean, SD) and (F) mean fluorescence
intensity of ICAM-1 expression in indicated TMC subsets from two independent experiments (filled and open symbols) with each symbol representing an in-
dividual mouse. (C, E, F) For normalization of cell number (C and E) or ICAM-1 expression (F), the mean value for each TMC subset in the control group was set to
1. The value for each individual mouse (control or Ltbr/) was then divided by this mean. ***p < 0.001 (two-tailed Mann-Whitney test).
(G) Representative plots of ICAM-1 and VCAM-1 expression on PDGFRb+PDPN+ TMC from 7 w old Rag1/ and age-matched control mice. Results are
representative plots from five mice/group from two independent experiments. Numbers in plots are percentage of cells within indicated quadrants.Cell Isolation
Cell suspensions of thymus, LNs, and RTOC/RLOC grafts were prepared with
liberase TM (0.32 Wunsch U ml1, Roche Diagnostics) and DNase I (50 Kunitz
U ml1, Sigma-Aldrich) as previously described (Sitnik et al., 2012). For time
course analysis of inguinal LN stroma, embryonic and early postnatal tissue
was digested with collagenase P (1 mg ml1, Roche Diagnostics) and DNase
I (50 Kunitz U ml1, Sigma-Aldrich) at 37C for 45 min. Stromal cells were
enriched by immunomagnetic depletion of CD45+ cells by MACS (Miltenyi
Biotech) and thereafter stained with antibodies for analysis and cell sorting.
Isolation of adipose tissue stromal vascular fraction (SVF) was performed as
described (Church et al., 2014) with modifications. Briefly, subcutaneous adi-
pose tissue was digested with liberase TM (0.32 Wunsch U ml1, Roche
Diagnostics) and DNase I (50 Kunitz U ml1, Sigma-Aldrich) in high-glucose
GlutaMAX-supplemented DMEMwith 10mMHEPES (Invitrogen) and 4% fatty
acid-free BSA (Sigma-Aldrich) at 37C for 55 min using an orbital shaker
(350 rpm). The suspension was passed through a 100 mm nylon mesh filter
(BD Biosciences), and the floating adipocyte fraction was removed by centri-
fugation at 4003 g for 6 min. The resulting SVF pellet was sequentially filtered
through a 70 mm and a 40 mm filter.
RTOC and RLOC
For RTOC, EpCAM+CD45 TEC (2.5–3.5 3 105 cells/RTOC) and CD45+ thy-
mocytes (0.75–1.83 105 cells/RTOC) were sorted from single cell suspensions
of 0.5% trypsin-EDTA (Invitrogen) digested E14.5–E15.5 thymi and re-aggre-
gated with EYFP+ TMC (0.13–0.72 3 105 cells/graft) or ATMC (0.5–1 3 105
cells/graft). For RLOC, E19.5 mesenteric LNs were digested with collagenase2386 Cell Reports 14, 2375–2388, March 15, 2016 ª2016 The AuthorP (1mgml1) and DNase I (50 Kunitz Uml1, Sigma-Aldrich) at 37C for 45min
and resulting single-cell suspensions (5–7 3 105 cells per re-aggregate)
combined with EYFP+ cells as described above. Cell suspensions were then
used to establish RTOC and RLOC as previously described (Be´ne´zech et al.,
2012; White et al., 2008), incubated in 5% CO2 at 37
C for 1–2 days and
grafted under the kidney capsule of 5- to 12-week-old wild-type female
recipients.
Real-Time RT-PCR
For analysis of 2-week-old TMC subsets, total RNA was extracted from 5–73
104 sorted cells using RNeasy Micro Kit (QIAGEN), reverse transcribed with
SuperScript III and a 1:1 mixture of oligo-dT and random oligonucleotide hex-
amers (all from Invitrogen). Quantitative PCR was performed using Maxima
SYBR Green qPCR Master Mix (Fisher Scientific) in a MyiQ Single Color-
Real-Time PCR detection System (Bio-Rad). Gene expression was calculated
using comparative dCT method and normalized to Gapdh. Primer sequences
are listed in Table S3.
Microarray Analysis
RNA was prepared from TMC and LNMC (pooled inguinal, brachial, and axil-
lary LN) subsets sorted from 3 (TMC) and 10–11 (LNMC) 2-week-old mice
per experiment. Isolated RNA from three individual experiments was amplified
and prepared for hybridization to the Affymetrix Mouse Gene 1.1 ST Array in a
genomics core facility: Center of Excellence for Fluorescent Bioanalytics (KFB,
University of Regensburg, Germany) and analyzed as described in the Supple-
mental Experimental Procedures.s
Statistical Analyses
Statistical analysis was performed using unpaired two-tailed Student’s test or
two-tailed Mann-Whitney non-parametric test as indicated (*p < 0.05,
**p < 0.01, ***p < 0.001).ACCESSION NUMBERS
The accession number for the microarray data reported in this paper is NCBI
GEO: GSE76974.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2016.02.033.
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